Business Wire

Mother Who Lost Infant Son to Medical Error to Join Panel at World Patient Safety, Science & Technology Summit

Del

New mother Deahna Visscher was feeling hopeful. Although her son Grant had been born with a heart defect, he was doing very well after surgery. Just 11-days old, doctors felt he could soon leave the hospital. But that didn’t happen. A nurse incorrectly inserted a feeding tube piercing the little infant’s trachea and filling his lungs with fluid. “The nurse asked me to go out into the hall and ask for help,” recalls Deahna. “I told them my son was turning blue and I watched as 20 staff members tried to resuscitate him. “ Grant was pronounced dead at 9:10 p.m.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180222005694/en/

Deahna Visscher will share her personal experience of losing her 11-day old son to a medical error.  ...

Deahna Visscher will share her personal experience of losing her 11-day old son to a medical error. (Photo: Business Wire)

Since that tragic night in 2008, Deahna Visscher has become a fierce patient advocate. The Patient Safety Movement Foundation (PSMF) is happy to announce her participation in a compelling panel on Nasogastric Feeding and Draining Tube Placement and Verification at the 6th Annual World Patient Safety, Science & Technology Summit on Saturday, February 24, 2018. Feeding and draining tubes are used routinely in hospitals and a recent study showed that 59% of nasogastric feeding tubes are misplaced in newborn children less than four weeks old, causing serious harm and in some cases death.1

Since Grant’s tragic death, Children’s Hospital Colorado has crafted procedures to ensure that such errors are not repeated. Their procedures and those of a multi-disciplinary experts were utilized in creating a new “Actionable Patient Safety Solutions” (APSS) developed by the PSMF which will be released publicly during the summit.

What is Nasogastric Feeding and Draining Tube Placement and Verification and why is it critical to patient safety? Nasogastric tubes (NGTs) are a commonly used in clinical practice for decompression or for administering nutrition, fluids and medications.

Studies of adult patients report NGT misplacement with serious harm to patients in 1.3 to 3.2% of tube placements (Gilbertson 2011, Bourgault 2009). A 2009 study of tube placements in neonates (infants less than four weeks old) showed that 59% of NGTs are misplaced the majority of these in the esophagus (October 2009).

The 6th Annual World Patient Safety panelists are:

Moderator Frances Healey , PhD, RN, Deputy Director of Patient Safety, National Health Service Improvement – Dr. Healey’s role includes leading the National Patient Safety Alerting System and clinical review teams of all nationally reported death and severe harm incidents.

Panelists include:

  • Beth Lyman, MSN, RN, CNSC , Senior Program Coordinator, Children’s Mercy Kansas City - Ms. Lyman is a member of the board of directors of the American Society of Parenteral and Enteral Nutrition. She worked with the board to develop the New Opportunities for Verification of Enteral tube Location (NOVEL) project which is an inter-organization, inter-disciplinary and international effort to promote best practice for NG tube placement verification.
  • Deahna Visscher , Patient Advocate – Since the death of her son in 2008Ms. Visscher has been on a mission to prevent further deaths from misplaced feeding tubes. She sits on the Patient Safety and Reliability Committee at Children’s Hospital Colorado and the New Opportunities for Verification of Enteral tube Location (NOVEL) project.
  • Christine Peyton , RN, Clinical Nurse Specialist, Children’s Hospital Colorado – Ms. Peyton promotes, develops and implements evidence-based best practices for pediatric nursing. She’s a clinical expert on revision and development of policies and guidelines for pediatric cardiology and critical care.
  • David Kershenobich , MD, Director General, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubiran – Former member of the Board of Governors of the National University of Mexico (UNAM) (2005-2012), Dr. Kershenobich served as Mexico’s Surgeon General from October 2011 to June 2012 and is Past President of the International Association for the Study of the Liver and the National Academy of Medicine of Mexico. He is an Honorary Fellow of the Royal College of Physicians, England.

For more information, please visit the Patient Safety Movement Foundation website. Members of the media may request a press pass by visiting http://bit.ly/2mCeyay or by contacting Tanya Lyon – phone (949) 351-2858 or email tanya.lyon@patientsafetymovement.org.

1 AM Bourgault, MA Halm. Feeding tube placement in adults: safe verification method for blindly inserted tubes.. Am J Crit Care 18, 73-6 (2009).

About Patient Safety Movement Foundation:

More than 200,000 U.S. patients and three million worldwide die each year from preventable causes. The Patient Safety Movement Foundation (PSMF) was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare to reduce that number of preventable deaths to zero by 2020 (0X2020). Improving patient safety requires a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. The PSMF works with all stakeholders to address problems with actionable solutions. The Foundation also convenes the World Patient Safety, Science and Technology Summit bringing together some of the world’s best minds for thought-provoking discussions and new ideas that challenge the status quo. By presenting specific, high-impact solutions to meet patient safety challenges, called Actionable Patient Safety Solutions, encouraging medical technology companies to share the data their products are purchased for, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, the Patient Safety Movement Foundation is working toward zero preventable deaths by 2020. Visit http://patientsafetymovement.org/.

Contact information

Patient Safety Movement Foundation
Tanya Lyon, 949-351-2858
tanya.lyon@patientsafetymovement.org

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Price f(x) Files Petitions with US Patent and Trademark Office to Invalidate Vendavo’s Patents and Launches a Counter Lawsuit17.12.2018 07:08Pressemelding

Price f(x), the global leader in cloud pricing software, has filed petitions for “Covered Business Method (“CBM”) Review” of four Vendavo patents, and will imminently file a fifth, which together will cover challenges to all of the patent claims that Vendavo has asserted in litigation between the parties. In Price f(x)’s view, each of Vendavo’s patents qualifies for the specialized CBM procedure created by US Congress to “crackdown on low-quality business method patents.” Price f(x)’s petitions challenge Vendavo’s patents on a variety of grounds, including in all cases that the claims are directed to patent-ineligible abstract ideas (e.g., math for pricing of products), and in many cases that Vendavo simply tried to claim more than it actually invented. The petitions are now pending in the U.S. Patent Office, which should make an initial ruling on Price f(x)’s petitions in approximately six months. Price f(x) is concurrently moving to stay the patent portion of the parties’ litigation

ABB: Shaping a leader focused in digital industries17.12.2018 06:16Pressemelding

Fundamental actions to focus, simplify and lead in digital industries for enhanced customer value and shareholder returns Focus of portfolio on digital industries through divestment of Power Grids Divestment of Power Grids to Hitachi expands existing partnership and strengthens Power Grids as a global infrastructure leader with enhanced access to markets and financing Enterprise Value of $11 billion for 100% of Power Grids, equivalent to an EV/op. EBITA multiple of 11.2x1 Crystallizing value from the transformation of Power Grids including doubling operational EBITA margin since 20142 ABB initially to retain 19.9 percent in the equity of carved-out Power Grids to ensure transition; pre-defined exit option on 19.9 percent equity at fair market value with floor price at 90 percent of agreed Enterprise Value, exercisable by ABB three years after closing Closing expected by first half of 20203 ABB intends to return 100% of the estimated net cash proceeds of $7.6-7.8 billion4 from the 80.1%

AURAK Gains SACSCOC Accreditation15.12.2018 10:49Pressemelding

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00